
|Articles|March 25, 2014
Covance Expands Global Biologics Capabilities
Covance announced it is expanding its large molecule bioanalytical space
Advertisement
Covance announced it is expanding its large molecule bioanalytical space co-located with Covance’s central laboratory facility in Indianapolis, IN to grow its global biologics capabilities. The expansion, which is planned to open during the second half of 2014, is doubling the company’s large molecule capacity. With this expansion, Covance expects to add 100 new positions over the next five years. This investment will enable Covance to further leverage its small and large molecule bioanalytical expertise while providing scientific, logistic, and regulatory synergies for clients.
Read the full release
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Recruitment in the Age of AI: Q&A with John Worden, Javara
2
What It Actually Means to Embed the Patient Voice in Trial Design
3
Beyond Compliance: NetraMark's Joseph Geraci, PhD, on Making AI-Driven Patient Subgroups Explainable
4
What This Study Means for Sponsors Still Struggling to Justify RBQM at Scale
5




